Intellia Therapeutics stock price
인텔리아 테라퓨틱스NASDAQ:NTLA · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →Intellia Therapeutics last closed at $12.26 (+1.16%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -4.1×. Its overall grade ranks 507 of 739 stocks in Healthcare.
About this company
Intellia Therapeutics last closed at $12.26 (+1.16%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 507/739
Valuation grade B-
Related stocks
- Regeneron PharmaceuticalsCustomer
유전자편집 치료제 공동개발 파트너
- NovartisCustomer
INTELLIA의 연구·개발 협력 및 잠재 상업화 파트너
- AstraZenecaCustomer
유전자편집 치료제 관련 협력 파트너
About Intellia Therapeutics
- What technical signals does Intellia Therapeutics (NTLA) have?
- Intellia Therapeutics current technical signals: MACD bullish cross.
- Is Intellia Therapeutics a cup-and-handle pattern?
- No. Intellia Therapeutics has no valid Cup signal right now.
- What published figures are available for Intellia Therapeutics?
- Market cap: $1.42B. Trailing 12 months PER: -4.1×. Latest quarter PBR: 2.25×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Intellia Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).